This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Skin and subcutaneous tissue infections
  • /
  • Review of the pharmacokinetics of dalbavancin, a r...

Review of the pharmacokinetics of dalbavancin, a recently approved lipoglycopeptide antibiotic

Read time: 1 mins
Published:1st Jul 2017
Author: Dash RP, Babu RJ, Srinivas NR.
Availability: Pay for access, or by subscription
Ref.:Infect Dis (Lond). 2017;49(7):483-492
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest